Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Human Resources for Health|March 16, 2022
Analysing 3429 digital supervisory interactions between Community Health Workers in Uganda and Kenya: the development, testing and validation of an open access predictive machine learning web appJames O'Donovan, Ken Kahn, MacKenzie MacRae, et al.
Infection and Immunity|October 27, 2004
Strain-specific humoral response to a polymorphic malaria vaccineChristian Flück, Tom Smith, Hans-Peter Beck, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2005
Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant proteinMyriam Arévalo-Herrera, Yezid Solarte, María Fernanda Yasnot, et al.
Protein Expression and Purification|August 4, 2006
Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tagRichard L Shimp, Laura B Martin, Yanling Zhang, et al.
Infection and Immunity|November 20, 2002
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic responseMichael C Kennedy, Jin Wang, Yanling Zhang, et al.
Infection and Immunity|June 24, 2005
posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidateBirgitte Giersing, Kazutoyo Miura, Richard Shimp, et al.
Journal of Immunological Methods|May 22, 2007
Formulation of vaccines containing CpG oligonucleotides and alumJoan A Aebig, Gregory E D Mullen, Gelu Dobrescu, et al.
International Journal of Molecular Sciences|October 13, 2021
Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous AntigensRoberta Di Benedetto, Renzo Alfini, Martina Carducci, et al.
The Journal of Biological Chemistry|July 16, 2014
Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsOmar Rossi, Isabella Pesce, Carlo Giannelli, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Human Resources for Health|March 16, 2022
Analysing 3429 digital supervisory interactions between Community Health Workers in Uganda and Kenya: the development, testing and validation of an open access predictive machine learning web appJames O'Donovan, Ken Kahn, MacKenzie MacRae, et al.
Infection and Immunity|October 27, 2004
Strain-specific humoral response to a polymorphic malaria vaccineChristian Flück, Tom Smith, Hans-Peter Beck, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2005
Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant proteinMyriam Arévalo-Herrera, Yezid Solarte, María Fernanda Yasnot, et al.
Protein Expression and Purification|August 4, 2006
Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tagRichard L Shimp, Laura B Martin, Yanling Zhang, et al.
Infection and Immunity|November 20, 2002
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic responseMichael C Kennedy, Jin Wang, Yanling Zhang, et al.
Infection and Immunity|June 24, 2005
posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidateBirgitte Giersing, Kazutoyo Miura, Richard Shimp, et al.
Journal of Immunological Methods|May 22, 2007
Formulation of vaccines containing CpG oligonucleotides and alumJoan A Aebig, Gregory E D Mullen, Gelu Dobrescu, et al.
International Journal of Molecular Sciences|October 13, 2021
Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous AntigensRoberta Di Benedetto, Renzo Alfini, Martina Carducci, et al.
The Journal of Biological Chemistry|July 16, 2014
Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsOmar Rossi, Isabella Pesce, Carlo Giannelli, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
Pageof 13